FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

EXCLUSIVE: Supreme Court prayer grotto case could impact ‘every single zoning law’ in America, attorney says

‘Conspiracy’ Speculation Erupts After Botched Execution of Christa Pike: ‘There’s No Way’

Rerun of ‘America’s Most Wanted’ Leads to Arrest in Cold Case That Haunted Detectives for Decades

Mamdani pledges millions to combat antisemitism while leaving key question unresolved

Sleeper Senate race emerges as unexpected headache for Republicans ahead of midterms

Fox News Poll: Turek, Hinson in close Iowa Senate race

Watch: Comedian Pete Davidson Calls Out Mamdani on ‘Jimmy Kimmel Live’ – Right Before the Mayor Walks Onstage

GOP Senator Who Had a Party for His Dog Last Week Complains ICE Is ‘Dragging People Away’

Illinois officials released more than 500 criminal immigrants despite ICE detainers, House GOP report finds

France gripped by violent student riots attributed to far-left instigation

Lindsay Clancy’s motion for a finding of not guilty denied weeks after mistrial

Christa Pike’s attorneys say she’s in critical condition after botched lethal injections

Reporter’s Notebook: Congress dodged a fall shutdown, but the real fight looms

British authorities arrest dual national on suspicion of ‘preparation of terrorist acts’ in RAF Fairford case

Breaking: Execution of TN Woman Goes Bad: 2 Lethal Injections Leave Subject Snoring, Very Much Alive

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”